1. Home
  2. MCHX vs QNCX Comparison

MCHX vs QNCX Comparison

Compare MCHX & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • QNCX
  • Stock Information
  • Founded
  • MCHX 2003
  • QNCX 2012
  • Country
  • MCHX United States
  • QNCX United States
  • Employees
  • MCHX N/A
  • QNCX N/A
  • Industry
  • MCHX Business Services
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MCHX Consumer Discretionary
  • QNCX Health Care
  • Exchange
  • MCHX Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • MCHX 84.3M
  • QNCX 100.4M
  • IPO Year
  • MCHX 2004
  • QNCX 2019
  • Fundamental
  • Price
  • MCHX $1.83
  • QNCX $1.65
  • Analyst Decision
  • MCHX
  • QNCX Strong Buy
  • Analyst Count
  • MCHX 0
  • QNCX 6
  • Target Price
  • MCHX N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • MCHX 37.3K
  • QNCX 425.3K
  • Earning Date
  • MCHX 11-14-2025
  • QNCX 11-12-2025
  • Dividend Yield
  • MCHX N/A
  • QNCX N/A
  • EPS Growth
  • MCHX N/A
  • QNCX N/A
  • EPS
  • MCHX N/A
  • QNCX N/A
  • Revenue
  • MCHX $47,534,000.00
  • QNCX N/A
  • Revenue This Year
  • MCHX N/A
  • QNCX N/A
  • Revenue Next Year
  • MCHX $7.56
  • QNCX N/A
  • P/E Ratio
  • MCHX N/A
  • QNCX N/A
  • Revenue Growth
  • MCHX N/A
  • QNCX N/A
  • 52 Week Low
  • MCHX $1.26
  • QNCX $0.72
  • 52 Week High
  • MCHX $2.40
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 39.44
  • QNCX 41.38
  • Support Level
  • MCHX $1.73
  • QNCX $1.76
  • Resistance Level
  • MCHX $1.89
  • QNCX $1.88
  • Average True Range (ATR)
  • MCHX 0.09
  • QNCX 0.10
  • MACD
  • MCHX -0.00
  • QNCX -0.03
  • Stochastic Oscillator
  • MCHX 12.92
  • QNCX 0.00

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: